|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Influence of lower current densities on the residual stress and structure of thick nickel electrodeposits 显示文摘 | Siddhartha Pathak Marion Guinard Martine G C | 2011 | Surface & Coatings Technology2011，205，： | 1 |
| 2 | Markov chain monte carlo methods for stochastic volatility models显示文摘 | Siddhartha C Federico N and Neil S | 2002 | Journal of Econometrics2002，108，2： | 1 |
| 3 | Transgenic expression of hevein, the rubber tree lectin, in Indian mustard confers protection against Altemaria brassicae 显示文摘 | Siddhartha K Jaganatha C V Pulugurtha B K and Virendra L C | 2002 | Plant Science2002，162，3： | 1 |
| 4 | Mechanical properties and electri- cal conductivity of Cu-Cr and Cu-Cr-4% SiC nanocom- posites for thermo-electric applications 显示文摘 | Suhrit Mula Pankajini Sahani Pratihar S K Siddhartha Mal Carl C Koch | 2011 | Materials Science and Engineering A2011，528，1314： | 1 |
| 5 | A highly efficientsynthesis of the C13 side-chain of Taxol using Shibasaki' sasymmetric Henry reaction 显示文摘 | Jagat C B Siddhartha G J Joshodeep B el al | 2004 | Tetrahedron Lett2004，45，18： | 1 |
| 6 | Markov chain Monte Carlo methods for stochastic volatility models 显示文摘 | Siddhartha C Federico N Neil S | 2002 | Journal of Econometrics2002，108，2： | 1 |
| 7 | ICE1:a regulator of cold-induced transcriptome and freezing tolerance in Arabidopsis显示文摘 | VISWANATHAN C MASARU O SIDDHARTHA K | 2003 | Genes Dev2003，17，： | 1 |
| 8 | Development of a rhodamine-benzimidazol hybrid derivative as a novel FRET based chemosensor selective for trace level water显示文摘 | Siddhartha P Manjira M Buddhadeb S Somenath L Pabitra C | 2014 | RSC Advances2014，4，21： | 1 |
| 9 | ICE 1 :a regulator of cold induced transcription and freezing tolerance in Arabidopsis显示文摘 | Viswanathan C Masaru O Siddhartha K | 2003 | Genes Development2003，，17： | 1 |
| 10 | Strain Specificity in Antimicrobial Activity of Silver and Copper Nanoparticles 显示文摘 | JAYESH P R ARUP K C SIDDHARTHA P D | 2008 | Acta Biomaterialia2008，4，3： | 1 |
| 11 | Strain specificity in antimierobial activity of silver and copper nanoparticles 显示文摘 | Jayesh P R Arup K C Siddhartha P | 2008 | Acta Biomaterialia2008，4，3： | 1 |
| 12 | Dynamic control allocation for tracking time-varying control demand 显示文摘 | Arun K W C Siddhartha S Gosaidas R | 2008 | Journal of Guidance Control and Dynamics2008，31，4： | 1 |
| 13 | Impacts of communi- ty-based conservation on local communities in the AnnapumaConservation Area, Nepal显示文摘 | Siddhartha B B Peter A F Adrian C N | 2006 | Biodiversity and Conservation2006，3，： | 1 |
| 14 | Analysis of Multivariate Probit Models显示文摘 | Siddhartha C Edward G | 1998 | Biometrika1998，85，2： | 1 |
| 15 | Cancer screening and management in the transgender population:Review of literature and special considerations for gender affirmation surgery显示文摘BACKGROUND Literature focused on cancer screening and management is lacking in the transgender population.AIM To action to increase contributions to the scientific literature that drives the creation of cancer screening and management protocols for transgender and gender nonconforming(TGNC)patients.METHODS We performed a systematic search of PubMed on January 5th,2022,with the following terms:“TGNC”,OR“transgender”,OR“gender non-conforming”,OR“gender nonbinary”AND“cancer screening”,AND“breast cancer”,AND“cervical cancer”,AND“uterine cancer”,AND“ovarian cancer”,AND“prostate cancer”,AND“testicular cancer”,AND“surveillance”,AND“follow-up”,AND“management”.70 unique publications were used.The findings are discussed under“Screening”and“Management”categories.RESULTS Screening:Current cancer screening recommendations default to cis-gender protocols.However,long-term genderaffirming hormone therapy and loss to follow-up from the gender-specific specialties contribute to a higher risk for cancer development and possible delayed detection.The only known screening guidelines made specifically for this population are from the American College of Radiology for breast cancer.Management:Prior to undergoing Gender Affirmation Surgery(GAS),discussion should address cancer screening and management in the organs remaining in situ.Cancer treatment in this population requires consideration for chemotherapy,radiation,surgery and/or reconstruction.Modification of hormone therapy is decided on a case-by-case basis.The use of prophylactic vs aesthetic techniques in surgery is still debated.CONCLUSION When assessing transgender individuals for GAS,a discussion on the future oncologic risk of the sex-specific organs remaining in situ is essential.Cancer management in this population requires a multidisciplinary approach while the care should be highly individualized with considerations to social,medical,surgical and gender affirming surgery related specifications.Special considerations have to be made during planning for GAS as surgery will alter the anatomy and may render the organ difficult to sample for screening purposes.A discussion with the patient regarding the oncologic risk of remaining organs is imperative prior to GAS.Other special considerations to screening such as the conscious or unconscious will to unassociated with their remaining organs is also a key point to address.We currently lack high quality studies pertinent to the cancer topic in the gender affirmation literature.Further research is required to ensure more comprehensive and individualized care for this population. | Juliet C Panichella Sthefano Araya Siddhartha Nannapaneni Samuel G Robinson Susan You Sarah M Gubara Maria T Gebreyesus Theresa Webster Sameer A Patel Alireza Hamidian Jahromi | 2023 | World Journal of Clinical Oncology2023，14，7： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员